NEW YORK (GenomeWeb News) – Kevin Hrusovsky is resigning his post at PerkinElmer as senior VP and president of the Life Science and Technology division.

Hrusovsky will serve as a consultant to the company for up to one year, beginning in June.

Hrusovsky came to PerkinElmer through the company's acquisition of Caliper Life Sciences, where he was CEO and president.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.